Speaker Info
LDL Management for the Interventionalist
Q&A Moderator
Emmanouil Brilakis, MD, PhD, FSCAI
Minneapolis Heart Institute, Minneapolis, MN, USA
Introduction and Case Presentation
Emmanouil Brilakis, MD, PhD, FSCAI
Minneapolis Heart Institute, Minneapolis, MN, USA
The Impact of PCSK-9 Inhibition of Coronary Plaque: GLAGOV and Beyond
Subhash Banerjee, M.D., FSCAI
Dallas Veterans Affairs Medical Center, Dallas, TX, USA
PCSK-9 Inhibition: Clinical Trial Data
Payal Kohli, MD
Cherry Creek Heart, Denver, CO, USA
LDL Management: Guideline Recommendations
Michael Davidson, MD
University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA
Lipid Lowering in the COVID Era
Thomas Knickelbine, M.D., FSCAI
Minneapolis Cardiology Associates, Minneapolis, MN, USA
Index
--:--:--
--:--:--
Placeholder for warning

loading...